Ernal, Rosita S.
HRN: 01-25-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/09/2023
11/18/2023
IV
1.5g
Q8
Infected Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes